TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM $3.71B
1-Year Return
19.93%
This Quarter Return
+7.58%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$2.41B
AUM Growth
-$3.75B
(-61%)
Cap. Flow
-$4.05B
Cap. Flow
% of AUM
-167.82%
Top 10 Holdings %
Top 10 Hldgs %
31.78%
Holding
6,989
New
540
Increased
1,712
Reduced
3,626
Closed
686
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$142M |
| 2 |
TSMC
TSM
|
+$123M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$37.2M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
+$14.6M |
| 5 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$9.98M |
Top Sells
| 1 |
Apple
AAPL
|
+$293M |
| 2 |
Microsoft
MSFT
|
+$269M |
| 3 |
Amazon
AMZN
|
+$109M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$107M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$75M |
Sector Composition
| 1 | Technology | 21.73% |
| 2 | Healthcare | 7.69% |
| 3 | Consumer Discretionary | 6.84% |
| 4 | Financials | 6.5% |
| 5 | Industrials | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARI
2326
Apollo Commercial Real Estate
ARI
$1.46B
| $51K | ﹤0.01% |
4,805
-9,700
| -67% | -$103K |
|
|
CNTA
2327
Centessa Pharmaceuticals
CNTA
$2.93B
| $51K | ﹤0.01% |
16,171
+10,894
| +206% | +$34.4K |
|
2328
iShares S&P 500 Value ETF
IVE
$41B
| $51K | ﹤0.01% |
351
+65
| +23% | +$9.44K |
|
2329
US Global Jets ETF
JETS
$819M
| $51K | ﹤0.01% |
2,975
-14,213
| -83% | -$244K |
|
2330
Monro
MNRO
$541M
| $51K | ﹤0.01% |
1,121
-2,302
| -67% | -$105K |
|
2331
Cartesian Therapeutics
RNAC
$238M
| $51K | ﹤0.01% |
1,510
-577
| -28% | -$19.5K |
|
|
SKE
2332
Skeena Resources
SKE
$2.11B
| $51K | ﹤0.01% |
9,631
-260
| -3% | -$1.38K |
|
2333
Smith & Nephew
SNN
$16.2B
| $51K | ﹤0.01% |
1,917
-709
| -27% | -$18.9K |
|
2334
Spear Alpha ETF
SPRX
$99.2M
| $51K | ﹤0.01% |
4,295
-18,974
| -82% | -$225K |
|
2335
Univest Financial
UVSP
$881M
| $51K | ﹤0.01% |
1,941
-10,555
| -84% | -$277K |
|
2336
Worthington Enterprises
WOR
$3.04B
| $51K | ﹤0.01% |
1,674
-14,797
| -90% | -$451K |
|
2337
Zentalis Pharmaceuticals
ZNTL
$102M
| $51K | ﹤0.01% |
2,578
-3,443
| -57% | -$68.1K |
|
|
RCM
2338
DELISTED
R1 RCM Inc. Common Stock
RCM
| $51K | ﹤0.01% |
4,641
-37,884
| -89% | -$416K |
|
|
AAIC
2339
DELISTED
Arlington Asset Investment Corp.
AAIC
| $51K | ﹤0.01% |
17,394
-5,307
| -23% | -$15.6K |
|
2340
Constellium
CSTM
$2.13B
| $51K | ﹤0.01% |
4,317
-9,669
| -69% | -$114K |
|
2341
Clearway Energy Class C
CWEN
$3.29B
| $51K | ﹤0.01% |
1,623
-19,416
| -92% | -$610K |
|
2342
Farmers National Banc Corp
FMNB
$553M
| $51K | ﹤0.01% |
3,610
-2,886
| -44% | -$40.8K |
|
2343
Horizon Bancorp
HBNC
$826M
| $51K | ﹤0.01% |
3,388
-2,289
| -40% | -$34.5K |
|
2344
iShares MSCI ACWI ex US ETF
ACWX
$6.84B
| $50K | ﹤0.01% |
1,092
-1,100
| -50% | -$50.4K |
|
2345
Federal Agricultural Mortgage
AGM
$2.03B
| $50K | ﹤0.01% |
439
-632
| -59% | -$72K |
|
2346
BridgeBio Pharma
BBIO
$9.78B
| $50K | ﹤0.01% |
6,484
-10,311
| -61% | -$79.5K |
|
|
BBU
2347
Brookfield Business Partners
BBU
$2.39B
| $50K | ﹤0.01% |
2,949
+1,574
| +114% | +$26.7K |
|
2348
Bain Capital Specialty
BCSF
$950M
| $50K | ﹤0.01% |
4,218
+1,605
| +61% | +$19K |
|
2349
Community Trust Bancorp
CTBI
$1.02B
| $50K | ﹤0.01% |
1,099
-3,294
| -75% | -$150K |
|
2350
First Advantage
FA
$2.71B
| $50K | ﹤0.01% |
3,847
-1,397
| -27% | -$18.2K |
|